Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 5, 1999, Pages 951-958

  Chinn, Daniel M ^a   Chow, Steven ^a   Kim, Youn H ^a   Hoppe, Richard T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Extent of skin involvement; Mycosis fungoides; T2; T3; Topical nitrogen mustard; Total skin electron beam therapy

Indexed keywords

CHLORMETHINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; ELECTRON BEAM; ELECTRON THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RADIATION RESPONSE; SALVAGE THERAPY; SKIN LYMPHOMA; SKIN METASTASIS; TREATMENT INDICATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MECHLORETHAMINE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0032914564     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00517-3     Document Type: Article

References (34)

1. Kuzel T.M., Rownigk H.H., Rosen S.T. Mycosis fungoides and the sezary syndrome A review of pathogenesis, diagnosis, and therapy . J Clin Oncol. 9:1991;1298-1313.
2. Bunn P.A., Huberman M.S., Whang-Peng J., Schecter G.P., Guccion J.G., Mathews M.J., Gazdar A.F., Dunnick N.R., Fischmann A.B., Ihde D.C., Cohen M.H., Fossieck B., Minna J.D. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of high frequency of extracutaneous dissemination. Ann Int Med. 93:1980;223-230.
3. Hoppe R.T., Cox R.S., Fuks Z., Price N.M., Bagshaw M.A., Farber E.M. Electron beam therapy for mycosis fungoides The Stanford University experience . Cancer Treat Rep. 63:1979;691-700.
4. Kim Y.H., Bishop K., Varghese A., Hoppe R.T. Prognostic factors in erythrodermic mycosis fungoides and the sezary syndrome. Arch Dermatol. 131:1995;1003-1008.
5. Sausville E.A., Eddy J.L., Makuch R.W., Fischmann A.B., Schechter G.P., Matthews M., Glatstein E., Ihde D.C., Kaye F., Veach S.R., Phelps R., O'Connor T., Trepel J.B., Cotelingam J.D., Gazdar A.F., Minna J.D., Bunn P.A. Histopathologic staging at initial diagnosis of mycosis fungoides and the sezary syndrome. Definition of three distinctive prognostic groups. Ann Int Med. 109:1988;372-382.
6. Hoppe R.T., Wood G.S., Abel E.A. Mycosis fungoides and the sezary syndrome Pathology, staging, and treatment . Curr Prob Cancer. 14:1990;297-371.
7. Lo T.C., Salzman F.A., Moschella S.L., Tolman E.L., Wright K.A. Whole body surface electron irradiation in the treatment of mycosis fungoides. An evaluation of 200 patients. Radiology. 130:1979;453-457.
8. Haserick J.R., Richardson J.H., Grant D.J. Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. Cleve Clin Quart. 26:1959;144-147.
9. Kim Y.H., Jensen R.A., Watanabe G.L., Varghese A., Hoppe R.T. Clinical stage IA (limited patch and plaque) mycosis fungoides. Long-term outcome analysis. Arch Dermatol. 132:1996;1309-1313.
10. Bunn P.A., Lamberg S.I. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep. 63:1979;725-728.
11. Hoppe R.T., Fuks Z., Bagshaw M.A. Radiation therapy in the management of cutaneous T-cell lymphoma. Cancer Treat Rep. 63:1979;625-632.
12. Price N.M., Hoppe R.T., Deneau D.G. Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer. 52:1983;2214-2219.
13. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;475-480.
14. Gehan E.A. A generalized Wilcoxon test for comparing arbirary singly-censored samples. Biometrika. 52:1965;203-223.
15. Becker M., Hoppe R.T., Knox S.J. Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Int J Radiat Oncol Biol Phys. 32:1995;1445-1449.
16. Hoppe R.T., Abel E.A., Deneau D.G., Price N.M. Mycosis fungoides Management with topical nitrogen mustard . J Clin Oncol. 5:1987;1796-1803.
17. Vonderheid E.C., VanScott E.J., Johnson W.C., Grekin D.A., Asbell S.O. Topical chemotherapy and immunotherapy of mycosis fungoides. Intermediate term results. Arch Dermatol. 113:1977;454-462.
18. Quiros P.A., Kacinski B.M., Wilson L.D. Extent of involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam therapy. Cancer. 77:1996;1912-1917.
19. Jones G.W., Tadros A., Hodson D.I., Rosenthal D., Roberts J., Thorson B. Prognosis with newly diagnosed mycosis fungoides after total skin electron therapy of 30 or 35 Gy. Int J Radiat Oncol Biol Phys. 28:1994;839-845.
20. Vonderheid E.C., Tan E.T., Kantor A.F., Shrager L., Micaily B., Van Scott E.J. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T-cell lymphoma. J Am Acad Dermatol. 20:1989;416-428.
21. Ramsay D.L., Halperin P.S., Zeleniuch-Jacquotte A. Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol. 19:1988;684-691.
22. Quiros P.A., Jones G.W., Kacinski B.M., Braverman I.M., Heald P.W., Edelson R.L., Wilson L.D. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys. 38:1997;1027-1035.
23. Herrmann J.J., Roenigk H.H., Hurria A., Kuzel T.M., Samuelson E., Rademaker A.W., Rosen S.T. Treatment of mycosis fungoides with photochemotherapy (PUVA) Long-term follow-up . J Am Acad Dermatol. 33:1995;234-242.
24. Abel E.A., Sendagorta E., Hoppe R.T., Hu C.H. PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study. Arch Dermatol. 123:1987;897-901.
25. Roenigk H.H., Kuzel T.M., Skoutelis A.P., Springer E., Yu G., Caro W., Gilyon K., Variakojis D., Kaul K., Bunn P.A., Evans L., Rosen S.T. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol. 95:1990;1985-2058.
26. Honigsmann H., Brenner W., Rauschmeier W., Konrad K., Wolff K. Photochemotherapy for cutaneous T cell lymphoma. A follow-up study. J Am Acad Dermatol. 10:1984;238-245.
27. Kuzel T.M., Roenigk H.H., Samuelson E., Herrmann J.J., Hurria A., Rademaker A.W., Rosen S.T. Effectiveness of interferon alpha-2a combined with phototherapy for mycosis fungoides and the sezary syndrome. J Clin Oncol. 13:1995;257-263.
28. Duvic M., Lemak N.A., Redman J.R., Eifel P.J., Tucker S.L., Cabanillas F.F., Kurzrock R. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 34:1996;1022-1029.
29. Thomsen K., Hammar H., Molin L., et al. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol Suppl (Stockh). 69:1989;217-222.
30. Jones G., McLean J., Rosenthal D., Roberts J., Sauder D.N. Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and sezary syndrome). J Am Acad Dermatol. 26:1992;960-967.
31. Wilson L.D., Licata A.L., Braverman I.M., Edelson R.L., Heald P.W., Feldman A.M., Kacinski B.M. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. Int J Radiat Oncol Biol Phys. 32:1995;987-995.
32. Hallahan D.E., Griem M.L., Medenica M., Soltani K., Lorincz A.L., Baron J.M. Combined modality therapy for tumor stage mycosis fungoides. J Clin Oncol. 6:1988;1177-1183.
33. Wilson L.D., Cooper D.L., Goodrich A.L., Friedman N.D., Feldman A.M., Braverman I.M., Kacinski B.M. Impact of non-CTCL dermatologic diagnosis and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys. 28:1994;829-837.
34. Kaye F.J., Bunn P.A., Steinberg S.M., Stocker J.L., Ihde D.C., Rischmann A.B., Glatstein E.J., Schechter G.P., Phelps R.M., Foss F.M., Parlette H.L., Anderson M.J., Sausville E.A. A randomized trial comparing combination electron beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 321:1989;1784-1790.